About | Free Trial

Last Update

2016-05-04T00:00:00.000Z

This profile was last updated on // .

Is this you? Claim your profile.

Wrong Patrick Loustau?

Mr. Patrick Loustau D.

President

ZAFGEN, INC.

HQ Phone: (617) 622-4003

ZAFGEN, INC.

175 Portland Street 4Th Floor

Boston, Massachusetts 02114

United States

Company Description

Zafgen is a nimble, capital efficient virtual company that brings together leading experts in obesity and metabolic disease to address the underserved and growing population of people who are severely obese. Zafgen's singular focus is on advancing novel t ... more

Find other employees at this company (48)

Background Information

Employment History

Senior Vice President for Global Marketing and Medical Affairs
Novo Nordisk Inc

Senior Vice President for Global Commercialization
Bristol-Myers Squibb Company

Human Resources and Training Manager
Parke-Davis

Affiliations

Member of the Board of Directors for the Greater New York Chapter
American Diabetes Association

Education

Master of Business Administration degree

University

Master's degree
Business Administration
University of Bordeaux

Web References (38 Total References)


Patrick ...

www.sec.gov [cached]

Patrick Loustau

...
Patrick Loustau. Mr. Loustau has served as our President since June 2014. During his career, Mr. Loustau has developed a global business experience living and working in five countries and leading several Global and US businesses. From August 2010 to April 2014, Mr. Loustau served as SVP for Global Commercialization (Cardiovascular & Metabolics) at Bristol-Myers Squibb where he was instrumental in building the diabetes franchise, launching several blockbuster brands, making a major acquisition (Amylin) and divesting/transitioning the entire diabetes business to partner Astra-Zeneca. From May 1996 to July 2010, he spent 14 years at Novo Nordisk where he served as SVP for Global Marketing & Medical Affairs, VP, Sales Force and Managed Care/Government Affairs US, President & GM Canada (Toronto), Regional Business Director Sales US, Senior Director Marketing Diabetes US and in sales and marketing roles of increasing responsibility in France. Mr. Loustau launched his career in 1989 with Parke-Davis as an HR and Training Manager and in multiple commercial roles. Mr. Loustau holds a Maitrise in Physiology from the University Paris-XI in Orsay, a DEA in Psychology from the University Paris-X in Nanterre and a DESS in Human Resources and Marketing from the Enterprise Administration Institute in Bordeaux. He also completed Harvard Business School’s General Management Program.


Management - Zafgen

ir.zafgen.com [cached]

Patrick Loustau

...
Patrick Loustau President
Mr. Loustau has more than 20 years of experience in US and global management with up to $10.7B P&L in the biopharmaceutical industry. He has broad experience in... read more
...
Image of Patrick Loustau
...
Patrick Loustau President
Mr. Loustau has more than 20 years of experience in US and global management with up to $10.7B P&L in the biopharmaceutical industry. He has broad experience in creating and implementing differentiated global and market strategies, from clinical development through life cycle management and business development.
Most recently, Mr. Loustau was the SVP for Global Commercialization (Cardiovascular & Metabolics) at Bristol-Myers Squibb. He had previously been with Novo Nordisk, where he held roles as the SVP for Global Marketing & Medical Affairs (based in Copenhagen), VP, Sales Force and Managed Care/Government Affairs (in Princeton, NJ), President & GM (Toronto), Regional Business Director Sales and Senior Director Marketing Diabetes (both also in Princeton), and Project Leader - Business Acceleration (for Germany, USA & Canada). Mr. Loustau joined Novo Nordisk as a Neurology Brand Manager and then became Marketing Director. He began his career with Parke-Davis in Paris, France as an HR and Training Manager.
Mr. Loustau is a member of the Board of Directors for the Greater New York Chapter of the American Diabetes Association and has participated in numerous athletic fundraising events for healthcare education and research.


Zafgen Appoints Patrick ...

ir.zafgen.com [cached]

Zafgen Appoints Patrick Loustau as President CAMBRIDGE, Mass., July 1, 2014 (GLOBE NEWSWIRE) -- Zafgen, Inc. (Nasdaq:ZFGN), a biopharmaceutical company dedicated to significantly improving the health and well-being of patients affected by obesity, today announced the appointment of Patrick Loustau to the position of President. Mr. Loustau has broad experience in creating and implementing diff...


Patrick ...

ir.zafgen.com [cached]

Patrick Loustau

President
...
Patrick Loustau
...
Patrick Loustau
...
Patrick Loustau. Mr. Loustau has served as our President since June 2014. From August 2010 to April 2014, Mr. Loustau served as SVP for Global Commercialization (Cardiovascular & Metabolics) at Bristol-Myers Squibb. From May 1996 to July 2010, he held roles as SVP for Global Marketing & Medical Affairs, VP, Sales Force and Managed Care/Government Affairs, President & GM (Toronto), Regional Business Directors Sales and Senior Director Marketing Diabetes and Project Leader-Business Acceleration at Novo Nordisk. Mr. Loustau launched his career with Parke-Davis as an HR and Training Manager in 1989. Mr. Loustau holds a Maitrise in Physiology from the University Paris-XI in Orsay, a DEA in Psychology from the University Paris-X in Nanterre and a DESS in Human Resources and Marketing from the Enterprise Administration Institute in Bordeaux.
...
Patrick Loustau
...
Represents base salary earned by Mr. Loustau for services as our President during 2014. Mr. Loustau’s employment with us commenced on June 16, 2014 and his annual base salary during this period was $400,000.
...
Consists of Simple IRA contribution in the amount of $3,907 and reimbursement for relocation costs in the amount of $25,425 as per Mr. Loustau’s employment agreement.
...
Patrick Loustau . On June 3, 2014, we entered into an offer letter with Mr. Loustau for the position of President. Mr. Loustau’s employment has no specified term, but can be terminated at will by either party. Mr. Loustau currently receives a base salary of $406,000, which is subject to review and adjustment in accordance with company policy. Mr. Loustau is also eligible for an annual merit bonus with a target bonus opportunity of 35% of his base salary, payable at the discretion of the Board of Directors, based upon performance. Mr. Loustau is eligible to participate in our employee benefit plans generally available to our executive employees, subject to the terms of those plans. He is also eligible to severance pay and health benefits for three months upon termination without cause or for good reason, each as defined in the offer letter.
...
Furthermore, pursuant to Mr. Loustau’s offer letter, 25% of unvested stock options will be accelerated such that the shares underlying such
...
Patrick Loustau
...
Under the terms of Mr. Loustau’s stock option agreement, 25% of the shares vest on June 16, 2015 and the remaining unvested shares will vest in equal monthly installments through June 16, 2018.


...

www.sec.gov [cached]

0001610902 Loustau Patrick C/O ZAFGEN, INC. 175 PORTLAND STREET, 4TH FLOOR BOSTON MA 02114 0 1 0 0 President

Similar Profiles

Other People with this Name

Other people with the name Loustau

Emeline Loustau
Arysta Projex Inc

Marcelo Loustau
TechTarget

Avlynn Loustau
Bidvest Bank Limited

Josefina Loustau
PLOCAN

Arthur Loustau
SLS Hotel

Browse ZoomInfo's Business Contact Directory by City

Browse ZoomInfo's
Business People Directory

Browse ZoomInfo's
Advanced Company Directory